Skip to main navigation Skip to search Skip to main content

A long-term follow-up study for Multiple Sclerosis patients who have completed the Alemtuzumab Extension Study (CAMMS03409)

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date02/5/16 → 02/4/21

Funding

  • Genzyme Corporation: $34,061.75